Zobrazeno 1 - 10
of 461
pro vyhledávání: '"W. Hinterberger"'
Autor:
V. Buxhofer-Ausch, M. Mollik, R. Schiessel, G. Hamilton, A. Reiner-Concin, Christoph Ausch, M. Stampfl, W. Hinterberger, E. Kitzweger, E. Ogris
Publikováno v:
Colorectal Disease. 12:776-782
Aim The study aimed to evaluate the incidence of disseminated tumour cells (DTCs) in bone marrow (BM) preoperatively and during follow up and to correlate these with established risk factors in patients with colorectal cancer. Method We prospectively
Autor:
Hildegard T. Greinix, W. Hinterberger, Peter Kalhs, Felix Keil, G. Mitterbauer, Oskar A. Haas, E. Reiter, Klaus Lechner, Werner Rabitsch
Publikováno v:
Leukemia & Lymphoma. 40:215-218
We report on a 31-year old female patient who relapsed with CML in blast crisis 12 years after a successful BMT for CML in chronic phase from her HLA-identical sister. Because of her good performance status and the long time elapsed since her first B
Autor:
I. Rech-Weichselbraun, R. Ruckser, E. M. Kittl, W. Hinterberger, G. Haberhauer, K. Bauer, S. Selleny
Publikováno v:
Rheumatology International. 16:181-186
Serum levels of soluble CD44 variant proteins including sequences encoded by exon v5 and exon v6 (sCD44v5, sCD44v6) were determined in patients with inflammatory rheumatic diseases: 56 with rheumatoid arthritis (RA+) and 31 with miscellaneous inflamm
Autor:
E.-W. Schwarze, W Geilen, H Hinkelbein, J Enzian, B. Krüger, H. Gerhartz, Markus Loeffler, R. Fuchs, H. Bartels, Hans Tesch, W Hinterberger, U Hagen-Aukamp, E Hiller, Hiltrud Nisters-Backes, U. Rühl, Volker Diehl, W. Gassmann, M. Sieber, Michael Pfreundschuh, Jeremy Franklin, Claudio Cartoni, Peter Koch, Dirk Hasenclever, Hartmut Kirchner, Gottfried Dölken
Publikováno v:
Journal of Clinical Oncology. 15:2275-2287
PURPOSE To determine the appropriate irradiation dose after four cycles of modern combination chemotherapy in nonbulky involved field (IF/BF) and noninvolved extended-field (EF/IF) sites in patients with intermediate-stage Hodgkin's disease (HD). MAT
Publikováno v:
Aktuelle Rheumatologie. 19:201-204
Autor:
R. Schiessel, U. Olszewski, C. Ausch, E. Ogris, V. Buxhofer-Ausch, Gerhard Hamilton, W. Hinterberger
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 35(11)
Background Soluble cytokeratin 18 (CK18; M65) and a caspase-cleaved fragment of CK18 (M30) have been used as biomarkers, corresponding to tumor cell death and apoptosis, respectively. Methods In the present study, M30 was quantified for the first tim
Publikováno v:
Zeitschrift für Gastroenterologie. 46